Golden Meds operates dispensaries that provide medicinal and recreational marijuana services to customers in Denver and Colorado Springs. The company is self-described as a staple in the cannabis community, serving both recreational and medical cannabis patients.

Golden Meds

Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through Domestic Operations and International Operations segments. The company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. In addition, it offers flowers, pre-rolls, flower pods, and dry-herb vaporizer cartridges; concentrates for vaporizing, such as pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, including distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. Further, the company provides hemp-based CBD and cannabigerol products. The company was founded in 2010 and is headquartered in New York, New York.

Metric
Company Name	Golden Meds	Curaleaf Holdings, Inc.
Symbol		CURA
MSH ID	COM:GOLDENMEDSCO	COM:CURALEAF
Market	PRIVATE	STOCKS
Sector	Consumer Goods	Healthcare
Industry	Cannabis	Drug Manufacturers - Specialty & Generic
Country	US	US
Stage
Employee Count		5.65K
Website	goldenmedsco.com	curaleaf.com
LinkedIn
Founders

Metric
Market Cap		2.70B
Enterprise Value
Monthly Web Traffic		2.08M
Web Traffic Growth		-0.40
Valuation
Raised Capital

Metric
Revenue		1.82B
Revenue (LTM)
Revenue (NTM)
Gross Profit		644.70M
EBITDA		343.90M
Operating Income		57.88M
Net Income		-379.53M
EPS		-0.52
Diluted EPS		-0.52
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin		0.38
Operating Profit Margin		0.04
EBITDA Margin		0.19
Net Profit Margin		-0.19
Return on Equity		-0.25
Return on Assets		-0.09
Return on Capital Employed		0.02

COM:GOLDENMEDSCO

Golden Meds

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio		-6.35
P/B Ratio		1.71
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio		1.37
EV Multiple		4.89

Metric
Days Sales Outstanding		18.73
Days Payables Outstanding		30.85
Days Inventory Outstanding		90.60
Operating Cycle		109.33
Cash Conversion Cycle		78.48
Asset Turnover		0.56

Metric
Operating Cash Flow		101.58M
Free Cash Flow		6.69M
Cash Flow to Debt		0.18
Operating Cash Flow/Sales		0.09
Free Cash Flow Yield		0.02

Metric
Cash & Equivalents		121.07M
Accounts Receivable		148.47K
Inventory		284.70M
Goodwill		826.27M
Debt to Capitalization		0.46
Debt to Assets		0.20
Current Ratio		0.72
Quick Ratio		0.50

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue		0.01
R&D to Revenue
SG&A to Revenue		0.21